Mission and History

Our mission is to make clinical trial participation more convenient, ultimately leading to the anticipated approval of new therapies for humankind.

PCM Trials’ mobile research services – driven by our Certified Mobile Research Nurses (CMRNs) – accelerate drug development and make clinical studies available to a broader range of patients by bringing research to individuals whenever and wherever it is convenient for them. Our patient-centric approaches reduce the burden of study participation and improve recruitment, retention, adherence, diversity, and data quality.

PCM Trials launched its mobile research offering in 2008, and we developed our CMRN certification program in 2010. Throughout our history, we have remained committed to a direct relationship with our nurse providers as the foundation for providing mobile visits that meet or exceed the high standards set by sponsors, CROs, and traditional clinical research sites.

PCM Trials is a division of Professional Case Management, the industry leader in delivering specialized in-home care to clients across the U.S. for more than 30 years. Patient centricity is in our DNA, and PCM Trials is committed to improving the quality of life and dignity for those who are suffering.  We live Our Values every day.

Medical nurse comforting senior patient
Young nurse in blue scrubs with arms crossed smiling at camera
Pediatrician listens to a young girl's heart while her smiling dad looks on
Healthcare provider smiling at the camera with arms crossed on a beige background
Male nurse with mask talking to elderly man at home

In July 2023, PCM’s Information Systems and Organization Security & Privacy Program teams received the prestigious CSO50 Award for the second time, an honor acknowledging outstanding achievements in security programs and initiatives. The award recognized PCM’s novel approach to centralize the monitoring of cyber activity across its entire footprint of devices, applications and networks, and to launch automated protective responses 24/7.